News

Delivering patient value discussed at EU Parliament

18 April 2019
EU
Asthma , COPD, Allergy, Food Allergy, Other Diseases
- Healthcare
To mark the 13th European Patients’ Rights Day, EFA attended the conference on ‘Delivering patient value throughout the healthcare system’ organised...

European Parliament Interest Group on Allergy and Asthma launches a Blueprint

27 March 2019
EU
Asthma , COPD, Allergy, Other Diseases
- Inequalities, - Healthcare, - Medicines
On 20th March, the European Parliament Interest Group on Allergy and Asthma, co-run by EFA and EAACI, organised at the European Parliament a Breakfast...

EPF: EuropeforPatients campaign

27 March 2019
EU
Asthma , COPD, Allergy, Other Diseases
The European Patients Forum (EPF), of which EFA is a long-standing member, has launched a campaign ahead of the EU elections called ‘europeforpatients’....

Rare diseases: A new platform to support better diagnosis and treatment

27 March 2019
EU
Asthma , COPD, Allergy, Food Allergy
- Healthcare, - Medicines
In light of the Rare Disease Day in February, the European Commission has launched a new online knowledge-sharing platform to support better diagnosis...

European Commission Manual for patients: Patients’ rights to accessing healthcare

27 March 2019
EU
Asthma , COPD, Allergy, Other Diseases
- Healthcare, - Medicines
The European Commission Directorate General for Health and Food Safety (DG SANTE) has published a manual for patients regarding their rights to access...

Asthma Allergy Denmark: Hay-fever and allergy high-school 2019

27 March 2019
Denmark
Asthma , Allergy
EFA Member Astma Allergi Denmark organises a Hay-fever and Allergy High School. During the event, attendees can ask questions and get advice from Astma-Allergy...

New COPD development prediction: the ALEC Project

27 March 2019
EU
COPD
- Healthcare, - Medicines
Although COPD has long been viewed as a predominantly smoking-related disease, there is increasing awareness that lifestyle and the environment contribute...

EFA continues to be the only patient organisation working with European Chemicals Agency

27 March 2019
EU
Asthma , COPD, Allergy, Food Allergy, Other Diseases
- Chemicals, - Healthcare
The European Chemicals Agency (ECHA) organised its annual Accredited Stakeholder Workshop on 21 March 2019 in Brussels to mainly discuss ECHA’s Strategic...

New IMI Project: 3TR

27 March 2019
EU
Asthma , COPD, Allergy
- Medicines
Despite the wide availability of treatments for autoimmune, inflammatory and allergic diseases, the response to therapy and the disease progression is...

Falsified medicines: New rules to enhance patients' safety

27 March 2019
EU
Asthma , COPD, Allergy
- Medicines
Falsified medicines are fake medicines that are dispensed as real, authorised, medicines. In reality, falsified medicines may contain inactive molecules,...

First guidance on new rules for certain medical devices by European Medical Agency

27 March 2019
EU
Asthma , COPD, Allergy, Other Diseases
- Medicines
The European Medicines Agency (EMA) has published a first set of guidelines to help prepare for obligations coming from the new EU legislation on medical...

Patient Access Partnership launches the Future of Healthcare in the EU at the EP

27 March 2019
EFA’s Susanna Palkonen, in her role as the chairperson of the Patient Access Partnership, launched a widely supported Statement on the Furure of Health...

European Parliament supports the adoption of an Indoor Air Quality Performance Certificate

27 March 2019
EU
Asthma , COPD, Allergy
- Air Quality, - Healthcare
On March 13th, the European Parliament plenary adopted the motion for a resolution ‘Clean Air for All: A Europe that Protects’, an initiative put forward...

EFA patient leaders make our Annual General Meeting 2019 in Brussels a success

27 March 2019
EU
Asthma , COPD, Allergy
On March 19th and 20th EFA celebrated the Annual General Meeting (AGM) of Members in Brussels, Belgium and launched the EFA annual report 2018, Shedding...

Allergy and respiratory patients present a European campaign calling for action for better care and prevention

27 March 2019
EU
Asthma , COPD, Allergy
On March 20th, the European Parliament Interest Group on Allergy and Asthma organised the last policy meeting of the current mandate, aimed at renewing...

Our takeaways from the ERS Satellite on COPD

27 March 2019
EU
COPD
- Medicines
FA took part in the last Satellite Precision Medicine training, organised by the European Respiratory Society (ERS) to deliver free cutting-edge education...

European Food Safety Authority discusses civil society concerns

18 February 2019
EU, Estonia, Finland
Asthma , COPD, Allergy, Food Allergy, Other Diseases
- Medicines
The use and presence of pesticides, and their classification as endocrine disruptors where among the top food-related health concerns that civil society...

EFA calls for a European Air Quality strategy at the European Health Parliament

18 February 2019
EU
Other Diseases
- Air Quality, - Chemicals, - Healthcare, - Medicines
EFA was invited to bring the perspective of allergy and airways diseases patients to a debate on environment and human health at the 3rd Plenary of the...

EU digital prescriptions system kicks off in Finland and Estonia

18 February 2019
EU
Asthma , COPD, Allergy, Other Diseases
- Healthcare, - Medicines
We welcome the initiative giving patients the possibility to use digital prescriptions: prescriptions issued by a doctor at home can be issued when going...

Exposure to 25 carcinogens and mutagens will be reduced in the workplace

18 February 2019
EU
Asthma , COPD
The third round of amendments on the Directive on Carcinogens and Mutagens at Work came to a close late January. The legislation seeks to impose obligatory...

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team